NewsRoom Articles - Page 230 of 256

TuesdayOct 03, 2017 9:00 am

Cannabis Market Extends across Numerous Industry Segments

CBDWire Editorial Coverage: Growth has been the dominant theme in the cannabis market. Estimates by Forbes put the legal cannabis market at a value of $7.2 billion (per a February 2017 report), and the market is expected to generate more jobs than government, manufacturing, or utilities in the coming years, according to the Bureau of Labor Statistics. Numerous industries are being impacted. Cultivation and medicine are just a couple of examples, but cannabis is showing a strong presence in the retail, consulting, and consumer sectors. SinglePoint, Inc. (SING) (SING Profile) has focused on business development in multiple segments thanks to…

MondayOct 02, 2017 12:24 pm

Algae Dynamics Corp. (ADYNF) Research Efforts Focus on Healthier Benefits of Cannabis Oils

Health conscious consumers favor cannabis oil extracts and edibles over smoking Recent survey shows 46% of Canadians would try cannabis-infused products Canadian cannabis oil extraction market expected to reach $1.7 billion by 2020 Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018. The company’s focus on developing proprietary research and products involving botanical oils derived from cannabis combines two important consumer demands – the well-known health benefits of cannabinoids and a smoke-free alternative to cannabis consumption. Nearly half of Canadians (46%) polled in August 2017 by Dalhousie University…

MondayOct 02, 2017 11:25 am

India Globalization Capital, Inc. (NYSE: IGC) to Launch Medical Dispensary Product for Alzheimer’s Disease

Product portfolio to include drugs and supplements Faster monetization of lead Alzheimer’s candidate as supplement Market valuation poised to soar It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly diverse and sophisticated. After all, the cannabis sativa plant incorporates over 400 chemical entities, of which more than 60 are cannabinoids. Even though cannabis has been used and cultivated by mankind for at least 6,000 years, it was only relatively recently, in 1899, that the first cannabinoid, cannabinol (CBN), was identified and isolated. With so much chemistry wrapped in its…

MondayOct 02, 2017 9:54 am

PotNetwork Holding, Inc. (POTN) Projected to Reach Greater than $30 Million in Revenues in FY2019, Per SeeThruEquity

In July 2017, POTN had a 30% jump in sales to nearly $1.5 million versus June 2017 Research report estimates $8.4 million in revenues in FY2017 and notes POTN plans for international expansion, with initial focus on China Aggressive marketing strategy and branding means more POTN sales and retail placement from increased exposure at trade and sporting events PotNetwork Holding, Inc. (OTC: POTN) revenues are projected to reach greater than $30 million by FY2019, $16.7 million in FY2018 and $8.4 million this fiscal year, according to SeeThruEquity, LLC (http://cnw.fm/QSUd2). POTN is a holding company for subsidiary First Capital Venture Co.,…

FridaySep 29, 2017 12:52 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Tech Discussed at “Cannabis in the Capital Markets” Event

Clinical studies of TurboCBD™ a topic of discussion at Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event Patents cover variety of lipophilic bio-actives, including cannabinoids, nicotine and vitamins Growing portfolio of intellectual property includes 19 patents filed across 44 countries Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), through its proprietary technology for delivering bioactive compounds in lipid formulations, offers licensed partners the ability to include cannabidiol (CBD) in a variety of ingestible products appropriate for medical patients and recreational users alike. In a new report, Grand View Research, Inc., states that the global market for medical cannabis alone is…

ThursdaySep 28, 2017 2:05 pm

Global Payout, Inc. (GOHE) CEO Discusses Innovative FINTECH Company’s Past, Present and Future

Innovative Global Reserve Platform enables seamless international payments “Banking in a box” Global Reserve Platform provides full front-to-back office processing for banks Solutions serve the global logistics industry, high-risk sectors and more In a recent interview (http://cnw.fm/1rsK8) with NetworkNewsWire, Global Payout, Inc. (OTC: GOHE) CEO James Hancock detailed where the innovative payment solutions company has been, where it is now, and where it plans to be in the future. Global Payout is a frontrunner in the FINTECH revolution (http://cnw.fm/F2sRA), offering versatile and innovative solutions for domestic and international organizations distributing money on a global scale. The company’s solutions include a…

WednesdaySep 27, 2017 3:51 pm

EVIO, Inc. (SGBYD) Changes Name, Adopts New Ticker Symbol and Announces a Reverse Stock Split

Name change to EVIO, Inc., from Signal Bay, Inc., reflects fact that EVIO Labs division generates majority of company volume New ticker symbol of EVIO will become effective October 3, 2017, for the legalized cannabis industry’s quality control testing and ancillary advisory services company Reverse stock split is positioned to attract institutional investors to provide funding for company’s vision of becoming a leading biotechnology firm in the cannabis industry EVIO, Inc. (OTCQB: SGBYD) has changed its name from Signal Bay, Inc. and also announced a reverse stock split (http://cnw.fm/Vk8tC). The life science company will also have a new ticker symbol,…

WednesdaySep 27, 2017 3:19 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targets Specific Diseases with its Proprietary Biotechnologies

Provisional patent application protects unique process yielding pharmaceutical grade, bio-identical cannabinoids Proprietary research allows production of synthetic cannabinoids for therapeutic use with certain diseases Early stage clinical trials are expected to begin in 2018 for a drug targeting a rare children’s skin disorder Imagine having a painful disease that causes your skin to blister at the slightest minor injury. Even just scratching an itch or accidentally rubbing against a rough object could cause peeling blisters and acute suffering. Epidermolysis bullosa, a genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States, currently has…

WednesdaySep 27, 2017 1:14 pm

Grey Cloak Tech Inc. (GRCK) Signs Letter of Intent to Acquire Eqova Life Sciences

Clinical-grade full spectrum hemp oil products created for licensed medical practitioners included Science-backed education, superior products meet requirements of medical profession Medical cannabinoid product revenue projected to reach $1.15 billion by 2020 Grey Cloak Tech Inc. (OTC: GRCK) recently announced that it has signed a binding Letter of Intent to purchase Eqova Life Sciences, a Colorado-based medically-focused company producing clinical-grade full spectrum hemp oil products. To date, no other hemp oil company has exclusively focused on the medical practitioner market, leaving this important segment largely underserved. Grey Cloak Tech, which is known for its click fraud prevention products, has been…

MondaySep 25, 2017 3:46 pm

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Attains $43M in Capital, Plans Significant Production Capacity Increase

Aaron Keay, CEO, says plans set for greater production capacity and strategy for global distribution in emerging markets Expansion of ABcann’s Vanluven facility underway, along with construction of the company’s 150,000 sq. ft. Kimmett facility Napanee, Ontario-based firm uses proprietary plant-growing technology and is pursuing opportunities in Australia and Germany ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) achieved working capital of $43 million from multiple financings, including private placements and strategic partnerships, during the six months ended June 30, 2017, it announced on August 29 (http://cnw.fm/1BXpf). ABcann manufactures and distributes medical cannabis under a license issued by Health Canada to…

News and publishing service for CBD related companies

Contact us: 512.354.7000